GALECTIN THERAPEUTICS INC's ticker is GALT and the CUSIP is 363225202. A total of 61 filers reported holding GALECTIN THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2014 | $207,000 | – | 13,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cutter & CO Brokerage, Inc. | 184,742 | $565,000 | 0.18% |
| D.A. DAVIDSON & CO. | 851,101 | $2,604,000 | 0.05% |
| AMUSSEN HUNSAKER ASSOCIATES LLC | 17,090 | $52,000 | 0.02% |
| SHEPHERD KAPLAN KROCHUK, LLC | 12,000 | $37,000 | 0.02% |
| IHT Wealth Management, LLC | 28,155 | $86,000 | 0.01% |
| OSAIC HOLDINGS, INC. | 1,012,430 | $3,098,000 | 0.01% |
| Ameritas Investment Company, LLC | 10,782 | $33,000 | 0.01% |
| Vivaldi Capital Management LP | 15,439 | $40,000 | 0.01% |
| CENTAURUS FINANCIAL, INC. | 15,614 | $48,000 | 0.01% |
| Geneos Wealth Management Inc. | 37,017 | $108,000 | 0.01% |